Atour(ATAT.US) Initiation: Buy for First-Stage Single-Brand Network Expansion
We expect Atour’s network to expand to 2,500+ in 2025 from the current 900+. We initiate Atour (ATAT US) with a BUY rating and target price of...
426 Views
Atour Lifestyle Holdings IPO Analysis
Atour Lifestyle Holdings (ATAT US) is a leading upper midscale hotel chain group in China is getting ready for an IPO in the US. We provide an in...
302 Views
ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
448 Views
ECM Weekly (27th June 2021) - Didi, Xpeng, Zylox, Dingdong, EBeauty, Chaoju Eye Care, Keymed Bio
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
420 Views
Atour Lifestyle Holdings IPO - Reasonable Valuation for a Fast-Growing Brand
Atour Lifestyle Holdings is the largest upper midscale hotel chain in China in terms of the number of rooms as of December 2020, as per Frost &...
457 Views